ID:CD86_HUMAN DESCRIPTION: RecName: Full=T-lymphocyte activation antigen CD86; AltName: Full=Activation B7-2 antigen; AltName: Full=B70; AltName: Full=BU63; AltName: Full=CTLA-4 counter-receptor B7.2; AltName: Full=FUN-1; AltName: CD_antigen=CD86; Flags: Precursor; FUNCTION: Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T- cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation. SUBUNIT: Homodimer. Interacts with MARCH8. Interacts with human herpesvirus 8 MIR2 protein (Probable). Interacts with adenovirus subgroup B fiber proteins and acts as a receptor for these viruses. INTERACTION: P16410:CTLA4; NbExp=2; IntAct=EBI-1030956, EBI-1030991; SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. TISSUE SPECIFICITY: Expressed by activated B-lymphocytes and monocytes. PTM: Polyubiquitinated; which is promoted by MARCH8 and results in endocytosis and lysosomal degradation. SIMILARITY: Contains 1 Ig-like C2-type (immunoglobulin-like) domain. SIMILARITY: Contains 1 Ig-like V-type (immunoglobulin-like) domain. WEB RESOURCE: Name=Wikipedia; Note=CD86 entry; URL="http://en.wikipedia.org/wiki/CD86";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P42081
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0002250 adaptive immune response GO:0002376 immune system process GO:0006955 immune response GO:0008284 positive regulation of cell proliferation GO:0016032 viral process GO:0019221 cytokine-mediated signaling pathway GO:0031295 T cell costimulation GO:0043017 positive regulation of lymphotoxin A biosynthetic process GO:0045086 positive regulation of interleukin-2 biosynthetic process GO:0045404 positive regulation of interleukin-4 biosynthetic process GO:0045630 positive regulation of T-helper 2 cell differentiation GO:0045893 positive regulation of transcription, DNA-templated GO:0046718 viral entry into host cell GO:0046854 phosphatidylinositol phosphorylation GO:0051897 positive regulation of protein kinase B signaling
LQ740457 - Sequence 11 from Patent WO2018083189. AK301237 - Homo sapiens cDNA FLJ58631 complete cds, highly similar to T-lymphocyte activation antigen CD86 precursor. AK316203 - Homo sapiens cDNA, FLJ79102 complete cds, highly similar to T-lymphocyte activation antigen CD86 precursor. AK294663 - Homo sapiens cDNA FLJ50144 complete cds, highly similar to T-lymphocyte activation antigen CD86 precursor. BC040261 - Homo sapiens CD86 molecule, mRNA (cDNA clone MGC:34413 IMAGE:5173789), complete cds. L25259 - Human CTLA4 counter-receptor (B7-2) mRNA, complete cds. JD203853 - Sequence 184877 from Patent EP1572962. AK291497 - Homo sapiens cDNA FLJ76858 complete cds, highly similar to Homo sapiens CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) (CD86), transcript variant 1, mRNA. JD297431 - Sequence 278455 from Patent EP1572962. AK313103 - Homo sapiens cDNA, FLJ93588, highly similar to Homo sapiens CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) (CD86), mRNA. U04343 - Human CD86 antigen mRNA, complete cds. FW340041 - Screening. DQ893787 - Synthetic construct Homo sapiens clone IMAGE:100008247; FLH164390.01L; RZPDo839F10161D CD86 molecule (CD86) gene, encodes complete protein. DQ890617 - Synthetic construct Homo sapiens clone IMAGE:100003247; FLH263530.01X; RZPDo839F09162D CD86 molecule (CD86) gene, encodes complete protein. KJ896564 - Synthetic construct Homo sapiens clone ccsbBroadEn_05958 CD86 gene, encodes complete protein. CR541844 - Homo sapiens full open reading frame cDNA clone RZPDo834D1232D for gene CD86, CD86 antigen (CD28 antigen ligand 2, B7-2 antigen); complete cds, without stopcodon. KU284848 - Homo sapiens CD86 antigen (CD86) mRNA, complete cds. JD298162 - Sequence 279186 from Patent EP1572962. JD566912 - Sequence 547936 from Patent EP1572962. JD102757 - Sequence 83781 from Patent EP1572962. JD324820 - Sequence 305844 from Patent EP1572962. JD097923 - Sequence 78947 from Patent EP1572962. JD298605 - Sequence 279629 from Patent EP1572962. JD538558 - Sequence 519582 from Patent EP1572962. JD348331 - Sequence 329355 from Patent EP1572962. JD294321 - Sequence 275345 from Patent EP1572962. JD261372 - Sequence 242396 from Patent EP1572962. JD444605 - Sequence 425629 from Patent EP1572962. JD437420 - Sequence 418444 from Patent EP1572962. JD339424 - Sequence 320448 from Patent EP1572962. JD151163 - Sequence 132187 from Patent EP1572962. JD058668 - Sequence 39692 from Patent EP1572962. JD566414 - Sequence 547438 from Patent EP1572962. JD067578 - Sequence 48602 from Patent EP1572962.
Biochemical and Signaling Pathways
BioCarta from NCI Cancer Genome Anatomy Project h_ctla4Pathway - The Co-Stimulatory Signal During T-cell Activation h_th1th2Pathway - Th1/Th2 Differentiation
Reactome (by CSHL, EBI, and GO)
Protein P42081 (Reactome details) participates in the following event(s):